Latest news
Loading news…
Isla Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Juan, NA - Puerto Rico, Puerto Rico Founded 2017 1-10 employees For Profit
Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Ticker
ILA
ASX - Australian Securities Exchange
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ILA
- Exchange
- ASX - Australian Securities Exchange
- IPO date
- Apr 13, 2021
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2017
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- San Juan, NA - Puerto Rico, Puerto Rico
- Region
- Latin America
- Exit date
- Apr 13, 2021
Signals & Scores
- Heat score
- Medium
- Growth score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- -0.1
- Trend (90d)
- -0.2
Key People at Isla Pharmaceuticals
Chief Financial Officer
1
professional contacts at Isla Pharmaceuticals
Contact execs at Isla Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Isla Pharmaceuticals
Loading news…
FAQs about Isla Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.